Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia
PR Newswire —
MINNEAPOLIS, Jan. 8, 2026 /PRNewswire/ -- Saluda Medical, Inc. (ASX:SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, announced that, as...